Targeting caveolae for vesicular drug transport
- 10 December 2002
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 87 (1-3) , 139-151
- https://doi.org/10.1016/s0168-3659(02)00358-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Caveolin-2-Deficient Mice Show Evidence of Severe Pulmonary Dysfunction without Disruption of CaveolaeMolecular and Cellular Biology, 2002
- Caveolae Are Highly Immobile Plasma Membrane Microdomains, Which Are not Involved in Constitutive Endocytic TraffickingMolecular Biology of the Cell, 2002
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Caveolin-1 Expression and Caveolae Biogenesis during Cell Transdifferentiation in Lung Alveolar Epithelial Primary CulturesBiochemical and Biophysical Research Communications, 1999
- Crowded Little CavesCellular Signalling, 1998
- Oligomerization of VIP21‐caveolin in vitro is stabilized by long chain fatty acylation or cholesterolFEBS Letters, 1996
- A detergent-free method for purifying caveolae membrane from tissue culture cells.Proceedings of the National Academy of Sciences, 1995
- Caveolin, a protein component of caveolae membrane coatsPublished by Elsevier ,1992
- Potocytosis: Sequestration and Transport of Small Molecules by CaveolaeScience, 1992
- THE FINE STRUCTURE OF THE GALL BLADDER EPITHELIUM OF THE MOUSEThe Journal of cell biology, 1955